Skip to main content
. 2020 Oct 28;5(5):e00990-20. doi: 10.1128/mSphere.00990-20

TABLE 2.

Characteristics of plasmids assembled in this study

Plasmid (GenBank accession no.) Gene of interest Size of plasmid (kbp) Replicon type (pMLST) ST Other AMR gene(s) [drug resistance]a Virulence gene(s)
p77 (MT077889) bla CTX-M-14 76 IncF (F2:A-:B-) 10 traT
p37 (MT077885) bla CTX-M-27 75 IncF (F2:A-:B-) 744 erm(B) [MA] traT
p62 (MT077887) bla CTX-M-27 69 IncF (F2:A-:B-) 10 traT
p1 (MT077880) bla CTX-M-15 171 IncF (F31:F36:A4:B1) 617 aadA5, aac(3)-IIa, aac(6′)-Ib-cr [AM]; blaOXA-1 [PE]; mph(A) [MA]; sul1, dfrA17 [TS]; catB3 [PH]; and tet(B) [TE] traT, sitA, iucC, iutA
p2 (MT077881) bla CTX-M-15 168 IncF (F31:F36:A4:B1) 58 aac(6′)-Ib-cr [AM]; blaOXA-1 [PE]; mph(A) [MA]; dfrA17 [TS]; catB3 [PH]; and tet(B) [TE] traT, sitA, iucC, iutA
p4 (MT077882) bla CTX-M-15 115 IncF (F48:A1:B49) 744 aac(3)-IIa [AM]; blaTEM-1b [PE]; mph(A) [MA]; and dfrA17 [TS] traT
p65 (MT077888) bla CTX-M-55 241 IncHI2 (ST-2) 165 aac(3)-IId, aadA2, aph(3″)-Ib, aph(3′)-Ia, aph(6)-Id [AM]; blaTEM-1b [PE]; mph(A) [MA]; sul1, dfrA12 [TS]; and tet(M) [TE] terC
p33 (MT077884) bla SHV-12 302 IncHI2 (ST-1) 641 aac(6′)-Ib3, aac(6′)-IIc, aph(6′)-Id, aph(3′)-Ib, aadA2, aac(6′)-Ib-cr [AM]; blaTEM-1b [PE]; qnrB2 [FL]; ere(A) [MA]; sul1, sul2, dfrA19 [TS]; tet(D) [TE]; and mcr-9 [CO] terC
p39 (MT077886) bla SHV-12 289 IncHI2 (ST-1) 1112 aph(3″)-Ib, aph(6′)-Id, aph(3′)-Ia, aac(6′)-IIc [AM]; blaTEM-1b [PE]; ere(A) [MA]; sul1 [TS]; catA2 [PH]; tet(D) [TE]; and mcr-9 [CO] terC
pCMY (MT816498) bla CMY-2 168 IncA/C2 (ST-3) 10 aac(3)-VIa, aadA24, aph(3″)-Ib, aph(6)-Id [PE]; sul1, sul2 [TS]; floR [PH]; and tet(A) [TE]
p23 (MT077883) qnrB77 59 IncN (unknown) 4981 aac(3)-VIa, aadA1 [AM]; and dfrA15 [TS]
a

AM, aminoglycosides; PE, penicillins; FL, fluoroquinolones; MA, macrolides; TS, trimethoprim/sulfonamide; PH, phenicols; TE, tetracyclines; CO, colistin.